Loading candles…
Lasa Supergenerics Ltd, incorporated in 2016, operates in the pharmaceutical, chemicals, and veterinary API sectors. The company manufactures, trades, processes, prepares, and treats chemicals, active pharmaceutical ingredients (APIs), pharmaceuticals, and veterinary APIs. It specializes in veterinary API production and follows a vertically integrated business model that spans discovery to delivery, encompassing research, manufacturing, and global marketing. The company is recognized for its expertise in catalyst chemistry and serves over 500 customers worldwide. Its geographic presence includes India, Australia, the Middle East, and China.
This page is a live market overview for LASA SUPERGENERICS LTD (LASA) on the NSE. As a listed security, LASA SUPERGENERICS LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for LASA before placing trades on tick2trade.
As of the latest feed, LASA last traded at ₹7.99 on NSE, up ₹0.14 (1.78%) from the previous close of ₹7.85. Today's session range is ₹7.85 – ₹8.17, against a 52-week band of ₹5.67 – ₹14.08. Traded volume today stands at 18.26K shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for LASA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether LASA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for LASA SUPERGENERICS LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in LASA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated LASA option chain page linked from this overview.
| To consider and approve the financial results for the period ended Jun 30, 2025 |
| 13 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 26 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.